CVMP opinions on veterinary medicinal products 

The Committee adopted by consensus a positive opinion for a marketing authorisation application for Alcort (hydrocortisole aceponate), from Nextmune Italy S.r.l., a new product for the alleviation of clinical signs associated with atopic dermatitis and for symptomatic treatment of inflammatory and pruritic dermatoses in dogs. 

The Committee adopted by consensus a positive opinion for a marketing authorisation application for Lexylan (cephalexin sodium), from Emdoka, a new generic product for the treatment of metritis, interdigital dermatitis, wounds and abcesses, treatment of septicemic mastitis in addition of an intramammary therapy, in cattle; infections of the respiratory tract, the uro-genital system, the skin, soft tissues and the gastro-intestinal system, in dogs, and Infections of the respiratory tract, the uro-genital system, the skin and soft tissues, in cats. 

The Committee adopted by consensus a positive opinion for a…